Olanzapine-Induced Neuroleptic Malignant Syndrome with Hypernatremia

被引：0
|
作者：
Tutuncu, Recep [1 ]
Gunay, Huseyin [1 ]
Balibey, Hakan [1 ]
机构：
[1] Etimesgut Mil Hosp, Ankara, Turkey
来源：
KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY | 2012年 / 22卷 / 02期
关键词：
Olanzapine; neuroleptic malignant syndrome; hypernatremia; RHABDOMYOLYSIS;
D O I：
10.5455/bcp.20120419122843
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Neuroleptic Malignant syndrome (NMS) is a rare but potentially fatal adverse effect of antipsychotics. In addition, hypernatremia may play a significant role before occurrence of NMS or it may develop secondary to acute renal failure. Herein we report the case of a 27 year old male patient who developed NMS with hypernatremia and acute renal failure following treatment with olanzapine.
引用
收藏
页码：184 / 186
页数：3
相关论文
共 50 条
  • [31] Neuroleptic Malignant Syndrome Induced by Olanzapine in a Patient with Huntington's Disease
    Lopez-Sendon Moreno, Jose Luis
    Palau Fayos, Jose Maria
    Diaz de Santiago, Alberto
    Garcia de Yebenes, Justo
    JOURNAL OF HUNTINGTONS DISEASE, 2012, 1 (01) : 31 - 32
  • [32] Recurrence of neuroleptic malignant syndrome with olanzapine treatment
    Gheorghiu, S
    Knobler, HY
    Drumer, D
    AMERICAN JOURNAL OF PSYCHIATRY, 1999, 156 (11): : 1836 - 1836
  • [33] Neuroleptic malignant syndrome associated with olanzapine therapy
    Apple, JE
    PSYCHOSOMATICS, 1999, 40 (03) : 267 - 268
  • [34] Neuroleptic Malignant Syndrome With the Addition of Aripiprazole to Olanzapine
    Marshall, Phillip B.
    Mellman, Thomas A.
    Nguyen, Shana Xuanlan C.
    AMERICAN JOURNAL OF PSYCHIATRY, 2008, 165 (11): : 1488 - 1489
  • [35] NEUROLEPTIC MALIGNANT SYNDROME ASSOCIATED WITH OLANZAPINE THERAPY
    Geka, A. -E.
    Avgeri, V.
    Psarra, V.
    Apatangelos, D.
    Garnetas, C.
    EUROPEAN PSYCHIATRY, 2010, 25
  • [36] Atypical neuroleptic malignant syndrome caused by olanzapine
    Nielsen, J
    Bruhn, AM
    ACTA PSYCHIATRICA SCANDINAVICA, 2005, 112 (03) : 238 - 240
  • [37] Olanzapine usage associated with neuroleptic malignant syndrome
    Philibert, RA
    Adam, LA
    Frank, FM
    Carney-Doebbeling, C
    PSYCHOSOMATICS, 2001, 42 (06) : 528 - 529
  • [38] Atypical neuroleptic malignant syndrome associated with olanzapine
    Reeves, RR
    Torres, RA
    Liberto, V
    Hart, RH
    PHARMACOTHERAPY, 2002, 22 (05): : 641 - 644
  • [39] Neuroleptic malignant syndrome after the initiation of olanzapine
    Levenson, JL
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 1999, 19 (05) : 477 - 478
  • [40] Neuroleptic Malignant Syndrome Secondary to Olanzapine Use
    Arumairaj, A. J.
    Vista, M.
    Chaudhari, A.
    Lee, S.
    Newman, T.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
12345